Skip to content

Application and dissemination of sequential three-step empirical therapy in the management of chronic cough

Application and dissemination of sequential three-step empirical therapy in the management of chronic cough

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-13003067
Enrollment
Unknown
Registered
2013-02-22
Start date
2013-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic cough

Interventions

Single cohort:Methoxyphenamine omeprazole domperidone

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 1675years, without gender restrict; 2. History of illness: History of recent illness: course of cough >8years, dry cough or little white sputum, without wheezing or fever. Past history: no history of upper respiratory tract infection in last 2 months; no smoking or withdrawa in last 2 years; no history of occupational dust or toxic or harmful gases exposure; without intake of ACEI in last 3 months; 3. Physical examination: no lung rales; 4. Auxiliary examination: Chest X-ray: no evident abnormality Pulmonary function: FEV1>80% predicted value, and FEV1/FVC>70% predicted value.

Exclusion criteria

Exclusion criteria: 1. Pregnant or breast-feeding women; 2. Allergic to certain drugs; 3. Participants with poor compliance; 4. Respiratory disease: history of occupational dust and toxic or harmful gases exposure; smoking in last 2 years; upper respiratory tract infection in last 2 months; complicated with COPD, interstitial pneumonia and tuberculosis; 5. Other internal disease: uncontrolled hypertension, intaking ACEI in last 3 months, serious arrhythmia, unstable blood sugar, serious hyperthyroidism or hypothyroidism, active digestive ulcer, decompensate cirrhosis, intestinal obstruction, serioud renal and hematological abnormality, thrombus syndrome and untreated seizure; 6. Psychiatric disease; 7. Surgical disease: serious difficulty urinating and recent operation history; 8. Ophthalmologic disease: glaucoma.

Design outcomes

Primary

MeasureTime frame
Blood routine, liver and renal function;Cough Symptoms Score;

Countries

China

Contacts

Public ContactZhongmin Qiu
qiuzhongmin@yahoo.com.hk+86 021 66111286

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026